Our top pick for
Building a portfolio
America's Car-Mart, Inc is an auto & truck dealerships business based in the US. Americas Car-Mart shares (CRMT) are listed on the NASDAQ and all prices are listed in US Dollars. Americas Car-Mart employs 1,750 staff and has a trailing 12-month revenue of around USD$791.3 million.
|52-week range||USD$35.18 - USD$129.7|
|50-day moving average||USD$106.4668|
|200-day moving average||USD$96.2396|
|Wall St. target price||USD$133.5|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$9.058|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Americas Car-Mart stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Americas Car-Mart's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Americas Car-Mart's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Americas Car-Mart shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Americas Car-Mart's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Americas Car-Mart's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Americas Car-Mart's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$90.7 million.
The EBITDA is a measure of a Americas Car-Mart's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$791.3 million|
|Operating margin TTM||10.99%|
|Gross profit TTM||USD$353.8 million|
|Return on assets TTM||8.42%|
|Return on equity TTM||20.14%|
|Market capitalisation||USD$728.7 million|
TTM: trailing 12 months
There are currently 244,987 Americas Car-Mart shares held short by investors – that's known as Americas Car-Mart's "short interest". This figure is 10.4% down from 273,482 last month.
There are a few different ways that this level of interest in shorting Americas Car-Mart shares can be evaluated.
Americas Car-Mart's "short interest ratio" (SIR) is the quantity of Americas Car-Mart shares currently shorted divided by the average quantity of Americas Car-Mart shares traded daily (recently around 50617.148760331). Americas Car-Mart's SIR currently stands at 4.84. In other words for every 100,000 Americas Car-Mart shares traded daily on the market, roughly 4840 shares are currently held short.
However Americas Car-Mart's short interest can also be evaluated against the total number of Americas Car-Mart shares, or, against the total number of tradable Americas Car-Mart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Americas Car-Mart's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Americas Car-Mart shares in existence, roughly 30 shares are currently held short) or 0.045% of the tradable shares (for every 100,000 tradable Americas Car-Mart shares, roughly 45 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Americas Car-Mart.
Find out more about how you can short Americas Car-Mart stock.
We're not expecting Americas Car-Mart to pay a dividend over the next 12 months.
Americas Car-Mart's shares were split on a 3:2 basis on 15 April 2005. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Americas Car-Mart shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Americas Car-Mart shares which in turn could have impacted Americas Car-Mart's share price.
Over the last 12 months, Americas Car-Mart's shares have ranged in value from as little as $35.18 up to $129.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Americas Car-Mart's is 1.4336. This would suggest that Americas Car-Mart's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
America's Car-Mart, Inc., through its subsidiaries, operates as an automotive retailer in the United States. The company primarily sells older model used vehicles and provides financing for its customers. As of December 17, 2020, it operated 151 dealerships in the South-Central United States. America's Car-Mart, Inc. was founded in 1981 and is based in Rogers, Arkansas.
Everything we know about the NLS Pharmaceutics Ltd IPO, plus information on how to buy in.
Everything we know about the GitLab IPO, plus information on how to buy in.
Everything we know about the Longeveron LLC IPO, plus information on how to buy in.
Everything we know about the Signify Health Inc IPO, plus information on how to buy in.
Everything we know about the Biophytis SA IPO, plus information on how to buy in.
Everything we know about the NexImmune Inc IPO, plus information on how to buy in.
Everything we know about the Adagene Inc IPO, plus information on how to buy in.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.